One Equity Partners Completes Investment in InfuCare Rx, a Leading Home Infusion Therapy Provider

NEW YORK – One Equity Partners (“OEP”), a middle market private equity firm, today announced that it has completed a strategic investment of InfuCare Rx (or “the Company”), a national provider of specialty infusion therapies and comprehensive clinical therapy management services to patients with complex conditions. Financial terms of the private transaction were not disclosed.
Read more

VYVGART™

InfuCare Rx is pleased to announce its selection as a limited distribution provider of VYVGART™. VVGART™ has been approved by the Food & Drug Administration (FDA) in the treatment of generalized myasthenia gravis (gMG) in adults who test positive for the antiacetylcholine receptor (AChR) antibody. InfuCare Rx is a leading data-driven nationwide specialty infusion provider. […]
Read more

2021 Scholarships

Congratulations to our 2021 InfuCare Rx Scholarship Recipients: Lily Ardente, Alexis Wade, Camden Alderman, Lily Ardente, Jessica Horne, Gabrielle Jenkins, and Nathan Mermilliod! The annual InfuCare Rx Scholarship Program offers three categories of financial support, awarded to individuals diagnosed with chronic conditions pursuing higher education. The scholarships are available to persons with bleeding disorders, neuromuscular conditions, and primary immunodeficiencies. Every year as our program grows, we receive a significant number of qualified applicants. In the end, these individuals stood out as people who represent hard work, perseverance, and dedication in the face of ongoing challenges.
Read more

NAIT

InfuCare Rx has been privileged to provide care for many moms with NAIT affected pregnancies. There is perhaps no greater satisfaction and joy than to celebrate with these families the successful arrival of their healthy baby. Fetomaternal alloimmune thrombocytopenia (FMAIT) also known as Neonatal alloimmune thrombocytopenia (NAIT) is a condition that can occur in pregnancy when the mother inherits a platelet antigen from the baby’s father that is a mismatch to her own. This mismatch causes her immune system to mount a response known as “alloimmunization” recognizing her developing fetus’s platelets as foreign, attacking and destroying them. Platelets are tiny cells in our blood that assist in the formation of clots to prevent bleeding. A platelet count below normal is called thrombocytopenia.
Read more

National UV Safety Month

National UV Safety Month July means fun in the sun for many people. But with the bright and sunny weather comes higher exposure to harmful Ultraviolet (UV) rays, which are the main cause of skin cells turning into cancer. Taking extra precautions with your skin this summer is more important than ever, as the rate of skin cancer has increased dramatically over the last decade. According to the American Cancer Society, skin cancer is the most common cancer in the United States. More skin cancers are diagnosed each year than all other cancers combined.
Read more